Exodus Point Capital Management, LP Matinas Bio Pharma Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.46 - $42.69 $21,170 - $1.96 Million	46,023 New	46,023 $23,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $285,493 - $418,723	-380,658 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$0.96 - $1.74 $237,388 - $430,267	-247,280 Reduced 39.38%	380,658 $400,000
Q4 2020 Feb 16, 2021	BUY	$0.76 - $1.47 $477,232 - $923,068	627,938 New	627,938 $854,000
Q3 2020 Nov 16, 2020	SELL	$0.67 - $0.96 $14,120 - $20,232	-21,076 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $157,605 - $278,840	-303,088 Reduced 93.5%	21,076 $16,000
Q1 2020 May 15, 2020	SELL	$0.6 - $2.31 $89,568 - $344,839	-149,281 Reduced 31.53%	324,164 $195,000
Q4 2019 Feb 14, 2020	BUY	$0.63 - $2.27 $298,270 - $1.07 Million	473,445 New	473,445 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $30,178 - $42,402	-38,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $22,920 - $53,862	38,200 New	38,200 $42,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.